Molecular bases of anorexia nervosa, bulimia nervosa and binge eating disorder: shedding light on the darkness

References

• Aardema, F. O. (2007). The menace within: obsessions and the self. International Journal of Cognitive Therapy, 21, 182–197. doi: 10.1891/088983907781494573
   Google Scholar
• Abizaid, A., Liu, Z.-W., Andrews, Z.B., Shanabrough, M., Borok, E., Elsworth, J.D., … Horvath, T.L. (2006). Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. Journal of Clinical Investigation, 116, 3229–3239. doi: 10.1172/JCI29867
   PubMed Web of Science ®Google Scholar
• Acevedo, S.F., Valencia, C., Lutter, M., & McAdams, C.J. (2015). Severity of eating disorder symptoms related to oxytocin receptor polymorphisms in anorexia nervosa. Psychiatry Research, 228, 641–648. doi: 10.1016/j.psychres.2015.05.040
   PubMed Web of Science ®Google Scholar
• Adan, R.A.H., Vanderschuren, L.J.M.J., & la Fleur, S.E. (2008). Anti-obesity drugs and neural circuits of feeding. Trends in Pharmacological Sciences, 29, 208–217. doi: 10.1016/j.tips.2008.01.008
   PubMed Web of Science ®Google Scholar
• Agras, W.S., Rossiter, E.M., Arnow, B., Schneider, J.A., Telch, C.F., Raeburn, S.D., … Koran, L.M. (1992). Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: A controlled comparison. American Journal of Psychiatry, 149, 82–87. doi: 10.1176/ajp.149.1.82
   PubMed Web of Science ®Google Scholar
• Aigner, M., Treasure, J., Kaye, W., & Kasper, S. & WFSBP Task Force On Eating Disorders. (2011). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. World Journal of Biological Psychiatry, 12, 400–443. doi: 10.3109/15622975.2011.602720
   PubMed Web of Science ®Google Scholar
• Altirriba, J., Poher, A.-L., & Rohner-Jeanrenaud, F. (2015). Chronic oxytocin Administration as a treatment against impaired leptin signaling or leptin resistance in obesity. Frontiers in Endocrinology, 6, 119. doi: 10.3389/fendo.2015.00119
   PubMed Web of Science ®Google Scholar
• Altman, S.E., & Shankman, S.A. (2009). What is the association between obsessive–compulsive disorder and eating disorders? Clinical Psychology Review, 29, 638–646. doi: 10.1016/j.cpr.2009.08.001
   PubMed Web of Science ®Google Scholar
• Alvarez-Crespo, M., Skibicka, K.P., Farkas, I., Molnár, C.S., Egecioglu, E., Hrabovszky, E., … Dickson, S.L. (2012). The amygdala as a neurobiological target for ghrelin in rats: Neuroanatomical, electrophysiological and behavioral evidence. PLoS One, 7, e46321. doi: 10.1371/journal.pone.0046321
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders. (5th ed.). Arlington, VA: American Psychiatric Publishing.
   Google Scholar
• Aponte, Y., Atasoy, D., & Sternson, S.M. (2011). AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training. Nature Neuroscience, 14, 351–355. doi: 10.1038/nn.2739
   PubMed Web of Science ®Google Scholar
• Appolinario, J.C., Bacaltchuk, J., Sichieri, R., Claudino, A.M., Godoy-Matos, A., Morgan, C., … Coutinho, W. (2003). A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. Archives of General Psychiatry, 60, 1109–1116. doi: 10.1001/archpsyc.60.11.1109
   PubMed Web of Science ®Google Scholar
• Aravich, P.F., Rieg, T.S., Lauterio, T.J., & Doerries, L.E. (1993). Beta-endorphin and dynorphin abnormalities in rats subjected to exercise and restricted feeding: Relationship to anorexia nervosa? Brain Research, 622, 1–8. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/790218710.1016/0006-8993(93)90794-N
   PubMed Web of Science ®Google Scholar
• Armougom, F., Henry, M., Vialettes, B., Raccah, D., & Raoult, D. (2009). Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and methanogens in anorexic patients. PloS One, 4, e7125. doi: 10.1371/journal.pone.0007125
   PubMed Web of Science ®Google Scholar
• Arnold, L.M., McElroy, S.L., Hudson, J.I., Welge, J.A., Bennett, A.J., & Keck, P.E. (2002). A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder. Journal of Clinical Psychiatry, 63, 1028–1033. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1244481710.4088/JCP.v63n1113
   PubMed Web of Science ®Google Scholar
• Atasoy, D., Betley, J.N., Su, H.H., & Sternson, S.M. (2012). Deconstruction of a neural circuit for hunger. Nature, 488, 172–177. doi: 10.1038/nature11270
   PubMed Web of Science ®Google Scholar
• Avena, N.M., & Bocarsly, M.E. (2012). Dysregulation of brain reward systems in eating disorders: Neurochemical information from animal models of binge eating, bulimia nervosa, and anorexia nervosa. Neuropharmacology, 63, 87–96. doi: 10.1016/j.neuropharm.2011.11.010
   PubMed Web of Science ®Google Scholar
• Avena, N.M., Rada, P., & Hoebel, B.G. (2008). Underweight rats have enhanced dopamine release and blunted acetylcholine response in the nucleus accumbens while bingeing on sucrose. Neuroscience, 156, 865–871. doi: 10.1016/j.neuroscience.2008.08.017
   PubMed Web of Science ®Google Scholar
• Avena, N.M., Rada, P., Moise, N., & Hoebel, B.G. (2006). Sucrose sham feeding on a binge schedule releases accumbens dopamine repeatedly and eliminates the acetylcholine satiety response. Neuroscience, 139, 813–820. doi: 10.1016/j.neuroscience.2005.12.037
   PubMed Web of Science ®Google Scholar
• Bacaltchuk, J., & Hay, P. (2001). Antidepressants versus placebo for people with bulimia nervosa. The Cochrane Database of Systematic Reviews, CD003391. doi: 10.1002/14651858.CD003391
   PubMedGoogle Scholar
• Bakhtazad, A., Vousooghi, N., Garmabi, B., & Zarrindast, M.R. (2016). CART peptide and opioid addiction: Expression changes in male rat brain. Neuroscience, 325, 63–73. doi: 10.1016/j.neuroscience.2016.02.071
   PubMed Web of Science ®Google Scholar
• Barlow, J., Blouin, J., Blouin, A., & Perez, E. (1988). Treatment of bulimia with desipramine: A double-blind crossover study. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie, 33, 129–133. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/328463010.1177/070674378803300211
   PubMed Web of Science ®Google Scholar
• Barth, K.S., & Malcolm, R.J. (2010). Disulfiram: An old therapeutic with new applications. CNS & Neurological Disorders Drug Targets, 9, 5–12. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/2020181010.2174/187152710790966678
   PubMed Web of Science ®Google Scholar
• Batterham, R.L., & Bloom, S.R. (2003). The gut hormone peptide YY regulates appetite. Annals of the New York Academy of Sciences, 994, 162–168. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1285131210.1111/j.1749-6632.2003.tb03176.x
   PubMed Web of Science ®Google Scholar
• Baver, S.B., Hope, K., Guyot, S., Bjørbaek, C., Kaczorowski, C., & O’connell, K.M.S. (2014). Leptin modulates the intrinsic excitability of AgRP/NPY neurons in the arcuate nucleus of the hypothalamus. Journal of Neuroscience, 34, 5486–5496. doi: 10.1523/JNEUROSCI.4861-12.2014
   PubMed Web of Science ®Google Scholar
• Becker, D.F., & Grilo, C.M. (2015). Comorbidity of mood and substance use disorders in patients with binge-eating disorder: Associations with personality disorder and eating disorder pathology. Journal of Psychosomatic Research, 79, 159–164. doi: 10.1016/j.jpsychores.2015.01.016
   PubMed Web of Science ®Google Scholar
• Bergen, A.W., van den Bree, M.B.M., Yeager, M., Welch, R., Ganjei, J.K., Haque, K., … Kaye, W.H. (2003). Candidate genes for anorexia nervosa in the 1p33-36 linkage region: Serotonin 1D and delta opioid receptor loci exhibit significant association to anorexia nervosa. Molecular Psychiatry, 8, 397–406. doi: 10.1038/sj.mp.4001318
   PubMed Web of Science ®Google Scholar
• Berner, L.A., Winter, S.R., Matheson, B.E., Benson, L., & Lowe, M.R. (2017). Behind binge eating: A review of food-specific adaptations of neurocognitive and neuroimaging tasks. Physiology & Behavior, 176, 59–70. doi: 10.1016/j.physbeh.2017.03.037
   PubMed Web of Science ®Google Scholar
• Billington, C.J., Briggs, J.E., Grace, M., & Levine, A.S. (1991). Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. American Journal of Physiology, 260(2 Pt 2), R321–R327. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1996719
   PubMedGoogle Scholar
• Blauwhoff-Buskermolen, S., Langius, J.A.E., Heijboer, A.C., Becker, A., de van der Schueren, M.A.E., & Verheul, H.M.W. (2017). Plasma ghrelin levels are associated with anorexia but not cachexia in patients with NSCLC. Frontiers in Physiology, 8, 119. doi: 10.3389/fphys.2017.00119
   PubMed Web of Science ®Google Scholar
• Blevins, J.E., Graham, J.L., Morton, G.J., Bales, K.L., Schwartz, M.W., Baskin, D.G., & Havel, P.J. (2015). Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys. American Journal of Physiology, Regulatory, Integrative and Comparative Physiology, 308, R431–R438. doi: 10.1152/ajpregu.00441.2014
   PubMed Web of Science ®Google Scholar
• Blundell, J.E., Goodson, S., & Halford, J.C. (2001). Regulation of appetite: Role of leptin in signalling systems for drive and satiety. International Journal of Obesity and Related Metabolic Disorders, 25 Suppl 1, S29–S34. doi: 10.1038/sj.ijo.0801693
   PubMed Web of Science ®Google Scholar
• Boersma, G.J., Liang, N.-C., Lee, R.S., Albertz, J.D., Kastelein, A., Moody, L.A., … Tamashiro, K.L. (2016). Failure to upregulate Agrp and Orexin in response to activity based anorexia in weight loss vulnerable rats characterized by passive stress coping and prenatal stress experience. Psychoneuroendocrinology, 67, 171–181. doi: 10.1016/j.psyneuen.2016.02.002
   PubMed Web of Science ®Google Scholar
• Boggiano, M.M., Chandler, P.C., Viana, J.B., Oswald, K.D., Maldonado, C.R., & Wauford, P.K. (2005). Combined dieting and stress evoke exaggerated responses to opioids in binge-eating rats. Behavioral Neuroscience, 119, 1207–1214. doi: 10.1037/0735-7044.119.5.1207
   PubMed Web of Science ®Google Scholar
• Booij, L., Casey, K.F., Antunes, J.M., Szyf, M., Joober, R., Israël, M., & Steiger, H. (2015). DNA methylation in individuals with anorexia nervosa and in matched normal-eater controls: A genome-wide study. International Journal of Eating Disorders, 48, 874–882. doi: 10.1002/eat.22374
   PubMed Web of Science ®Google Scholar
• Boraska, V., Davis, O.S.P., Cherkas, L.F., Helder, S.G., Harris, J., Krug, I., … Zeggini, E. (2012). Genome-wide association analysis of eating disorder-related symptoms, behaviors, and personality traits. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics?: The Official Publication of the International Society of Psychiatric Genetics, 159B, 803–811. doi: 10.1002/ajmg.b.32087
   PubMed Web of Science ®Google Scholar
• Boraska, V., Franklin, C.S., Floyd, J.A.B., Thornton, L.M., Huckins, L.M., Southam, L., … Bulik, C.M. (2014). A genome-wide association study of anorexia nervosa. Molecular Psychiatry, 19, 1085–1094. doi: 10.1038/mp.2013.187
   PubMed Web of Science ®Google Scholar
• Borgland, S.L., Chang, S.-J., Bowers, M.S., Thompson, J.L., Vittoz, N., Floresco, S.B., … Bonci, A. (2009). Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. Journal of Neuroscience, 29, 11215–11225. doi: 10.1523/JNEUROSCI.6096-08.2009
   PubMed Web of Science ®Google Scholar
• Brambilla, F., Monteleone, P., & Maj, M. (2009). Glucagon-like peptide-1 secretion in bulimia nervosa. Psychiatry Research, 169, 82–85. doi: 10.1016/j.psychres.2008.06.040
   PubMed Web of Science ®Google Scholar
• Brennan, B.P., Roberts, J.L., Fogarty, K.V., Reynolds, K.A., Jonas, J.M., & Hudson, J.I. (2008). Memantine in the treatment of binge eating disorder: An open-label, prospective trial. International Journal of Eating Disorders, 41, 520–526. doi: 10.1002/eat.20541
   PubMed Web of Science ®Google Scholar
• Breton, J., Legrand, R., Akkermann, K., Järv, A., Harro, J., Déchelotte, P., & Fetissov, S.O. (2016). Elevated plasma concentrations of bacterial ClpB protein in patients with eating disorders. International Journal of Eating Disorders, 49, 805–808. doi: 10.1002/eat.22531
   PubMed Web of Science ®Google Scholar
• Brewerton, T. (1992). Serotonin function in depression: Effects of seasonality? American Journal of Psychiatry, 149, 1277. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1482444
   PubMed Web of Science ®Google Scholar
• Brewerton, T.D. (2012). Antipsychotic agents in the treatment of anorexia nervosa: neuropsychopharmacologic rationale and evidence from controlled trials. Current Psychiatry Reports, 14, 398–405. doi: 10.1007/s11920-012-0287-6
   PubMed Web of Science ®Google Scholar
• Broberger, C., Johansen, J., Johansson, C., Schalling, M., & Hökfelt, T. (1998). The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proceedings of the National Academy of Sciences of the United States of America, 95, 15043–15048. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9844012
   PubMed Web of Science ®Google Scholar
• Brodie, M.J., Ben-Menachem, E., Chouette, I., & Giorgi, L. (2012). Zonisamide: Its pharmacology, efficacy and safety in clinical trials. Acta Neurologica Scandinavica. Supplementum, 126, 19–28. doi: 10.1111/ane.12016
   Google Scholar
• Brown, K.M.O., Bujac, S.R., Mann, E.T., Campbell, D.A., Stubbins, M.J., & Blundell, J.E. (2007). Further evidence of association of OPRD1 & HTR1D polymorphisms with susceptibility to anorexia nervosa. Biological Psychiatry, 61, 367–373. doi: 10.1016/j.biopsych.2006.04.007
   PubMed Web of Science ®Google Scholar
• Brown, M.R., Crim, J.W., Arata, R.C., Cai, H.N., Chun, C., & Shen, P. (1999). Identification of a Drosophila brain-gut peptide related to the neuropeptide Y family. Peptides, 20, 1035–1042. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1049942010.1016/S0196-9781(99)00097-2
   PubMed Web of Science ®Google Scholar
• Bulik-Sullivan, B., Finucane, H.K., Anttila, V., Gusev, A., Day, F.R., Loh, P.-R. Neale … , (2015). An atlas of genetic correlations across human diseases and traits. Nature Genetics, 47, 1236–1241. doi: 10.1038/ng.3406
   PubMed Web of Science ®Google Scholar
• Bulik, C.M., Kleiman, S.C., & Yilmaz, Z. (2016). Genetic epidemiology of eating disorders. Current Opinion in Psychiatry, 29, 383–388. doi: 10.1097/YCO.0000000000000275
   PubMed Web of Science ®Google Scholar
• Bulik, C.M., Sullivan, P.F., Tozzi, F., Furberg, H., Lichtenstein, P., & Pedersen, N.L. (2006). Prevalence, heritability, and prospective risk factors for anorexia nervosa. Archives of General Psychiatry, 63, 305–312. doi: 10.1001/archpsyc.63.3.305
   PubMed Web of Science ®Google Scholar
• Cabral, A., López Soto, E., Epelbaum, J., & Perelló, M. (2017). Is ghrelin synthesized in the central nervous system? International Journal of Molecular Sciences, 18, 638. doi: 10.3390/ijms18030638
   Web of Science ®Google Scholar
• Camardese, G., Picello, A., & Bria, P. (2008). Venlafaxine: Successful treatment in impulsive disorders. Psychiatry and Clinical Neurosciences, 62, 241–242. doi: 10.1111/j.1440-1819.2008.01763.x
   PubMed Web of Science ®Google Scholar
• Campbell, I.C., Mill, J., Uher, R., & Schmidt, U. (2011). Eating disorders, gene-environment interactions and epigenetics. Neuroscience and Biobehavioral Reviews, 35, 784–793. doi: 10.1016/j.neubiorev.2010.09.012
   PubMed Web of Science ®Google Scholar
• Capasso, A., Petrella, C., & Milano, W. (2009). Pharmacological profile of SSRIs and SNRIs in the treatment of eating disorders. Current Clinical Pharmacology, 4, 78–83. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1914950610.2174/157488409787236092
   PubMedGoogle Scholar
• Cardi, V., Corfield, F., Leppanen, J., Rhind, C., Deriziotis, S., Hadjimichalis, A., … Treasure, J. (2015). Emotional processing, recognition, empathy and evoked facial expression in eating disorders: An experimental study to map deficits in social cognition. PLoS One, 10, e0133827. doi: 10.1371/journal.pone.0133827
   PubMed Web of Science ®Google Scholar
• Cardinal, P., Bellocchio, L., Guzmán-Quevedo, O., André, C., Clark, S., Elie, M., … Cota, D. (2015). Cannabinoid type 1 (CB1) receptors on Sim1-expressing neurons regulate energy expenditure in male mice. Endocrinology, 156, 411–418. doi: 10.1210/en.2014-1437
   PubMed Web of Science ®Google Scholar
• Castrioto, A., Thobois, S., Carnicella, S., Maillet, A., & Krack, P. (2016). Emotional manifestations of PD: Neurobiological basis. Movement Disorders, 31, 1103–1113. doi: 10.1002/mds.26587
   PubMed Web of Science ®Google Scholar
• Chronwall, B.M., DiMaggio, D.A., Massari, V.J., Pickel, V.M., Ruggiero, D.A., & O’donohue, T.L. (1985). The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience, 15, 1159–1181. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/3900805
   PubMed Web of Science ®Google Scholar
• Cifani, C., Polidori, C., Melotto, S., Ciccocioppo, R., & Massi, M. (2009). A preclinical model of binge eating elicited by yo-yo dieting and stressful exposure to food: effect of sibutramine, fluoxetine, topiramate, and midazolam. Psychopharmacology, 204, 113–125. doi: 10.1007/s00213-008-1442-y
   PubMed Web of Science ®Google Scholar
• Clarke, J., Ramoz, N., Fladung, A.-K., & Gorwood, P. (2016). Higher reward value of starvation imagery in anorexia nervosa and association with the Val66Met BDNF polymorphism. Translational Psychiatry, 6, e829. doi: 10.1038/tp.2016.98
   PubMed Web of Science ®Google Scholar
• Clark, J.T., Kalra, P.S., Crowley, W.R., & Kalra, S.P. (1984). Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology, 115, 427–429. doi: 10.1210/endo-115-1-427
   PubMed Web of Science ®Google Scholar
• Clarke, T.K., Weiss, A.R.D., & Berrettini, W.H. (2012). The genetics of anorexia nervosa. Clinical Pharmacology and Therapeutics, 91, 181–188. doi: 10.1038/clpt.2011.253
   PubMed Web of Science ®Google Scholar
• Cowley, M.A., Smith, R.G., Diano, S., Tschöp, M., Pronchuk, N., Grove, K.L., … Horvath, T.L. (2003). The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron, 37, 649–661. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12597862
   PubMed Web of Science ®Google Scholar
• Cui, H., Moore, J., Ashimi, S.S., Mason, B.L., Drawbridge, J.N., Han, S., … Lutter, M. (2013). Eating disorder predisposition is associated with ESRRA and HDAC4 mutations. The Journal of Clinical Investigation, 123, 4706–4713. doi: 10.1172/JCI71400
   PubMed Web of Science ®Google Scholar
• Cuntz, U., Enck, P., Frühauf, E., Lehnert, P., Riepl, R.L., Fichter, M.M., & Otto, B. (2013). Cholecystokinin revisited: CCK and the hunger trap in anorexia nervosa. PloS One, 8, e54457. doi: 10.1371/journal.pone.0054457
   PubMed Web of Science ®Google Scholar
• Dailey, M.J., & Bartness, T.J. (2009). Appetitive and consummatory ingestive behaviors stimulated by PVH and perifornical area NPY injections. American Journal of Physiology, Regulatory, Integrative and Comparative Physiology, 296, R877–R892. doi: 10.1152/ajpregu.90568.2008
   PubMed Web of Science ®Google Scholar
• Davis, R., & Faulds, D. (1996). Dexfenfluramine. An updated review of its therapeutic use in the management of obesity. Drugs, 52, 696–724. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/911881910.2165/00003495-199652050-00007
   PubMed Web of Science ®Google Scholar
• DeGuzman, M., Shott, M.E., Yang, T.T., Riederer, J., & Frank, G.K.W. (2017). Association of elevated reward prediction error response with weight gain in adolescent anorexia nervosa. American Journal of Psychiatry, 174, 557–565. doi: 10.1176/appi.ajp.2016.16060671
   PubMed Web of Science ®Google Scholar
• Deshpande, S.A., Carvalho, G.B., Amador, A., Phillips, A.M., Hoxha, S., Lizotte, K.J., & Ja, W.W. (2014). Quantifying Drosophila food intake: comparative analysis of current methodology. Nature Methods, 11, 535–540. doi: 10.1038/nmeth.2899
   PubMed Web of Science ®Google Scholar
• Di Marzo, V., Goparaju, S.K., Wang, L., Liu, J., Bátkai, S., Járai, Z., … Kunos, G. (2001). Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature, 410, 822–825. doi: 10.1038/35071088
   PubMed Web of Science ®Google Scholar
• Dinan, T.G., & Cryan, J.F. (2017). The microbiome–gut–brain axis in health and disease. Gastroenterology Clinics of North America, 46, 77–89. doi: 10.1016/j.gtc.2016.09.007
   PubMed Web of Science ®Google Scholar
• DiPatrizio, N.V., & Piomelli, D. (2012). The thrifty lipids: Endocannabinoids and the neural control of energy conservation. Trends in Neurosciences, 35, 403–411. doi: 10.1016/j.tins.2012.04.006
   PubMed Web of Science ®Google Scholar
• Dixon, D.P., Ackert, A.M., & Eckel, L.A. (2003). Development of, and recovery from, activity-based anorexia in female rats. Physiology & Behavior, 80, 273–279. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1463722610.1016/j.physbeh.2003.08.008
   PubMed Web of Science ®Google Scholar
• Dostálová, I., Kopský, V., Dusková, J., Papezová, H., Pacák, K., & Nedvídková, J. (2005). Leptin concentrations in the abdominal subcutaneous adipose tissue of patients with anorexia nervosa assessed by in vivo microdialysis. Regulatory Peptides, 128, 63–68. doi: 10.1016/j.regpep.2004.12.029
   PubMedGoogle Scholar
• Dus, M., Lai, J.S.-Y., Gunapala, K.M., Min, S., Tayler, T.D., Hergarden, A.C., … Suh, G.S.B. (2015). Nutrient sensor in the brain directs the action of the brain–gut axis in Drosophila. Neuron, 87, 139–151. doi: 10.1016/j.neuron.2015.05.032
   PubMed Web of Science ®Google Scholar
• Eddy, K.T., Lawson, E.A., Meade, C., Meenaghan, E., Horton, S.E., Misra, M., … Miller, K.K. (2015). Appetite regulatory hormones in women with anorexia nervosa: Binge-eating/purging versus restricting type. Journal of Clinical Psychiatry, 76, 19–24. doi: 10.4088/JCP.13m08753
   PubMed Web of Science ®Google Scholar
• Egger, G., Liang, G., Aparicio, A., & Jones, P.A. (2004). Epigenetics in human disease and prospects for epigenetic therapy. Nature, 429, 457–463. doi: 10.1038/nature02625
   PubMed Web of Science ®Google Scholar
• Ehrlich, S., Weiss, D., Burghardt, R., Infante-Duarte, C., Brockhaus, S., Muschler, M.A., … Frieling, H. (2010). Promoter specific DNA methylation and gene expression of POMC in acutely underweight and recovered patients with anorexia nervosa. Journal of Psychiatric Research, 44, 827–833. doi: 10.1016/j.jpsychires.2010.01.011
   PubMed Web of Science ®Google Scholar
• El-Giamal, N., de Zwaan, M., Bailer, U., Strnad, A., Schüssler, P., & Kasper, S. (2003). Milnacipran in the treatment of bulimia nervosa: a report of 16 cases. European Neuropsychopharmacology, 13, 73–79. doi: 10.1016/S0924-977X(02)00126-8
   PubMed Web of Science ®Google Scholar
• Elias, C.F., Lee, C., Kelly, J., Aschkenasi, C., Ahima, R.S., Couceyro, P.R., … Elmquist, J.K. (1998). Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron, 21, 1375–1385. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9883730
   PubMed Web of Science ®Google Scholar
• Farci, A.M.G., Piras, S., Murgia, M., Chessa, A., Restivo, A., Gessa, G.L., & Agabio, R. (2015). Disulfiram for binge eating disorder: An open trail. Eating Behaviors, 16, 84–87. doi: 10.1016/j.eatbeh.2014.10.008
   PubMed Web of Science ®Google Scholar
• Fekete, C., Zséli, G., Singru, P.S., Kádár, A., Wittmann, G., Füzesi, T., … Lechan, R.M. (2012). Activation of anorexigenic pro-opiomelanocortin neurones during refeeding is independent of vagal and brainstem inputs. Journal of Neuroendocrinology, 24, 1423–1431. doi: 10.1111/j.1365-2826.2012.02354.x
   PubMed Web of Science ®Google Scholar
• Fernández-Aranda, F., Amor, A., Jiménez-Murcia, S., Giménez-Martínez, L., Turón-Gil, V., & Vallejo-Ruiloba, J. (2001). Bulimia nervosa and misuse of orlistat: Two case reports. International Journal of Eating Disorders, 30, 458–461. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11746308
   PubMed Web of Science ®Google Scholar
• Fetissov, S.O., Harro, J., Jaanisk, M., Järv, A., Podar, I., Allik, J., … Hökfelt, T. (2005). Autoantibodies against neuropeptides are associated with psychological traits in eating disorders. Proceedings of the National Academy of Sciences of the United States of America, 102, 14865–14870. doi: 10.1073/pnas.0507204102
   PubMed Web of Science ®Google Scholar
• Flak, J.N., & Myers, M.G. (2016). Minireview: CNS mechanisms of leptin action. Molecular Endocrinology (Baltimore, Md.), 30, 3–12. doi: 10.1210/me.2015-1232
   PubMed Web of Science ®Google Scholar
• Flament, M.F., Bissada, H., & Spettigue, W. (2012). Evidence-based pharmacotherapy of eating disorders. International Journal of Neuropsychopharmacology, 15, 189–207. doi: 10.1017/S1461145711000381
   PubMed Web of Science ®Google Scholar
• Föcker, M., Timmesfeld, N., Scherag, S., Bühren, K., Langkamp, M., Dempfle, A., … Hebebrand, J. (2011). Screening for anorexia nervosa via measurement of serum leptin levels. Journal of Neural Transmission (Vienna, Austria: 1996), 118, 571–578. doi: 10.1007/s00702-010-0551-z
   PubMed Web of Science ®Google Scholar
• Frank, G.K., Bailer, U.F., Henry, S.E., Drevets, W., Meltzer, C.C., Price, J.C., … Kaye, W.H. (2005). Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride. Biological Psychiatry, 58, 908–912. doi: 10.1016/j.biopsych.2005.05.003
   PubMed Web of Science ®Google Scholar
• Frieling, H., Römer, K.D., Scholz, S., Mittelbach, F., Wilhelm, J., De Zwaan, M., … Bleich, S. (2010). Epigenetic dysregulation of dopaminergic genes in eating disorders. International Journal of Eating Disorders, 43, 577–583. doi: 10.1002/eat.20745
   PubMed Web of Science ®Google Scholar
• Frith, C.D. (2008). Social cognition. Philosophical Transactions of the Royal Society of London Series B, Biological Sciences, 363, 2033–2039. doi: 10.1098/rstb.2008.0005
   PubMed Web of Science ®Google Scholar
• Fuss, J., Steinle, J., Bindila, L., Auer, M.K., Kirchherr, H., Lutz, B., & Gass, P. (2015). A runner’s high depends on cannabinoid receptors in mice. Proceedings of the National Academy of Sciences of the United States of America, 112, 13105–13108. doi: 10.1073/pnas.1514996112
   PubMed Web of Science ®Google Scholar
• Gaetani, S., Kaye, W.H., Cuomo, V., & Piomelli, D. (2008). Role of endocannabinoids and their analogues in obesity and eating disorders. Eating and Weight Disorders, 13, e42–e48. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19011363
   PubMedGoogle Scholar
• Gaetani, S., Romano, A., Provensi, G., Ricca, V., Lutz, T., & Passani, M.B. (2016). Eating disorders: From bench to bedside and back. Journal of Neurochemistry, 139, 691–699. doi: 10.1111/jnc.13848
   PubMed Web of Science ®Google Scholar
• Galusca, B., Prévost, G., Germain, N., Dubuc, I., Ling, Y., Anouar, Y., … Chartrel, N. (2015). Neuropeptide Y and α-MSH circadian levels in two populations with low body weight: Anorexia nervosa and constitutional thinness. PLoS One, 10, e0122040. doi: 10.1371/journal.pone.0122040
   PubMed Web of Science ®Google Scholar
• Gao, Q., & Horvath, T.L. (2008). Neuronal control of energy homeostasis. FEBS Letters, 582, 132–141. doi: 10.1016/j.febslet.2007.11.063
   PubMed Web of Science ®Google Scholar
• Garlapow, M.E., Huang, W., Yarboro, M.T., Peterson, K.R., & Mackay, T.F.C. (2015). Quantitative genetics of food intake in Drosophila melanogaster. PLoS One, 10, e0138129. doi: 10.1371/journal.pone.0138129
   PubMed Web of Science ®Google Scholar
• Garnock-Jones, K.P., & Keating, G.M. (2009). Atomoxetine: A review of its use in attention-deficit hyperactivity disorder in children and adolescents. Paediatric Drugs, 11, 203–226. doi: 10.2165/00148581-200911030-00005
   PubMedGoogle Scholar
• Gauthier, C., Hassler, C., Mattar, L., Launay, J.-M., Callebert, J., Steiger, H., … Godart, N. (2014). Symptoms of depression and anxiety in anorexia nervosa: Links with plasma tryptophan and serotonin metabolism. Psychoneuroendocrinology, 39, 170–178. doi: 10.1016/j.psyneuen.2013.09.009
   PubMed Web of Science ®Google Scholar
• Gorwood, P., Blanchet-Collet, C., Chartrel, N., Duclos, J., Dechelotte, P., Hanachi, M., … Epelbaum, J. (2016). New insights in anorexia nervosa. Frontiers in Neuroscience, 10, 256. doi: 10.3389/fnins.2016.00256
   PubMed Web of Science ®Google Scholar
• Gorwood, P., Kipman, A., & Foulon, C. (2003). The human genetics of anorexia nervosa. European Journal of Pharmacology, 480, 163–170. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1462335910.1016/j.ejphar.2003.08.103
   PubMed Web of Science ®Google Scholar
• Grilo, C.M., Crosby, R.D., Wilson, G.T., & Masheb, R.M. (2012). 12-month follow-up of fluoxetine and cognitive behavioral therapy for binge eating disorder. Journal of Consulting and Clinical Psychology, 80, 1108–1113. doi: 10.1037/a0030061
   PubMed Web of Science ®Google Scholar
• Grilo, C.M., Masheb, R.M., & Salant, S.L. (2005). Cognitive behavioral therapy guided self-help and orlistat for the treatment of binge eating disorder: A randomized, double-blind, placebo-controlled trial. Biological Psychiatry, 57, 1193–1201. doi: 10.1016/j.biopsych.2005.03.001
   PubMed Web of Science ®Google Scholar
• Groleau, P., Joober, R., Israel, M., Zeramdini, N., DeGuzman, R., & Steiger, H. (2014). Methylation of the dopamine D2 receptor (DRD2) gene promoter in women with a bulimia-spectrum disorder: associations with borderline personality disorder and exposure to childhood abuse. Journal of Psychiatric Research, 48, 121–127. doi: 10.1016/j.jpsychires.2013.10.003
   PubMed Web of Science ®Google Scholar
• Guerdjikova, A.I., McElroy, S.L., Winstanley, E.L., Nelson, E.B., Mori, N., McCoy, J., … Hudson, J.I. (2012). Duloxetine in the treatment of binge eating disorder with depressive disorders: A placebo-controlled trial. International Journal of Eating Disorders, 45, 281–289. doi: 10.1002/eat.20946
   PubMed Web of Science ®Google Scholar
• Guerdjikova, A.I., Mori, N., Casuto, L.S., & McElroy, S.L. (2016). Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine. Neuropsychiatric Disease and Treatment, 12, 833–841. doi: 10.2147/NDT.S80881
   PubMed Web of Science ®Google Scholar
• Haghighi, M., Jahangard, L., Mohammad-Beigi, H., Bajoghli, H., Hafezian, H., Rahimi, A., … Brand, S. (2013). In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive–compulsive disorders (OCD). Psychopharmacology, 228, 633–640. doi: 10.1007/s00213-013-3067-z
   PubMed Web of Science ®Google Scholar
• Hagler Robinson, A. (2009). Orlistat misuse as purging in a patient with binge-eating disorder. Psychosomatics, 50, 177–178. doi: 10.1176/appi.psy.50.2.177
   PubMed Web of Science ®Google Scholar
• Hald, J., & Jacobsen, E. (1948). A drug sensitizing the organism to ethyl alcohol. Lancet (London, England), 2, 1001–1004. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1810347510.1016/S0140-6736(48)91514-1
   PubMedGoogle Scholar
• Haleem, D. (2012). Serotonin neurotransmission in anorexia nervosa. Behavioural Pharmacology, 23, 478–495. doi: 10.1097/FBP.0b013e328357440d
   PubMed Web of Science ®Google Scholar
• Haleem, D., & Haider, S. (1996). Food restriction decreases serotonin and its synthesis rate in the hypothalamus. Neuroreport, 7, 1153–1156. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/881752210.1097/00001756-199604260-00011
   PubMed Web of Science ®Google Scholar
• Halmi, K.A. (2005). The multimodal treatment of eating disorders. World Psychiatry, 4, 69–73. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16633511
   PubMedGoogle Scholar
• Halmi, K.A. (2013). Perplexities of treatment resistence in eating disorders. BMC Psychiatry, 13, 292. doi: 10.1186/1471-244X-13-292
   PubMed Web of Science ®Google Scholar
• Halmi, K.A., Eckert, E., LaDu, T.J., & Cohen, J. (1986). Anorexia nervosa. Treatment Efficacy of Cyproheptadine and Amitriptyline, Archives of General Psychiatry, 43, 177–181. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/351187710.1001/archpsyc.1986.01800020087011
   PubMed Web of Science ®Google Scholar
• Hatsukami, D., Eckert, E., Mitchell, J.E., & Pyle, R. (1984). Affective disorder and substance abuse in women with bulimia. Psychological Medicine, 14, 701–704. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/659375810.1017/S0033291700015324
   PubMed Web of Science ®Google Scholar
• Hay, P.J., & Claudino, A.M. (2012). Clinical psychopharmacology of eating disorders: A research update. The International Journal of Neuropsychopharmacology, 15 (2), 209–22. doi: 10.1017/S1461145711000460
   PubMed Web of Science ®Google Scholar
• Hebebrand, J., Blum, W.F., Barth, N., Coners, H., Englaro, P., Juul, A., … Remschmidt, H. (1997). Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short-term weight restoration. Molecular Psychiatry, 2, 330–334. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9246674
   PubMed Web of Science ®Google Scholar
• Hebebrand, J., Exner, C., Hebebrand, K., Holtkamp, C., Casper, R.C., Remschmidt, H., … Klingenspor, M. (2003). Hyperactivity in patients with anorexia nervosa and in semistarved rats: Evidence for a pivotal role of hypoleptinemia. Physiology & Behavior, 79, 25–37. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12818707
   PubMed Web of Science ®Google Scholar
• Helder, S.G., & Collier, D.A. (2011). The genetics of eating disorders. Current Topics in Behavioral Neurosciences, 6, 157–175. doi: 10.1007/7854_2010_79
   PubMedGoogle Scholar
• Herisson, F.M., Brooks, L.L., Waas, J.R., Levine, A.S., & Olszewski, P.K. (2014). Functional relationship between oxytocin and appetite for carbohydrates versus saccharin. Neuroreport, 25, 909–914. doi: 10.1097/WNR.0000000000000201
   PubMed Web of Science ®Google Scholar
• Hermanussen, M., & Tresguerres, J.A.F. (2005). A new anti-obesity drug treatment: First clinical evidence that, antagonising glutamate-gated Ca2+ ion channels with memantine normalises binge-eating disorders. Economics and Human Biology, 3, 329–337. doi: 10.1016/j.ehb.2005.04.001
   PubMed Web of Science ®Google Scholar
• Hettes, S.R., Gonzaga, J., Heyming, T.W., Perez, S., Wolfsohn, S., & Stanley, B.G. (2003). Dual roles in feeding for AMPA/kainate receptors: Receptor activation or inactivation within distinct hypothalamic regions elicits feeding behavior. Brain Research, 992, 167–178. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1462505610.1016/j.brainres.2003.08.032
   PubMed Web of Science ®Google Scholar
• Hinney, A., Kesselmeier, M., Jall, S., Volckmar, A.-L., Föcker, M., Antel, J. Hebebrand … , (2017). Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass index. Molecular Psychiatry, 22, 192–201. doi: 10.1038/mp.2016.71
   PubMed Web of Science ®Google Scholar
• Hnasko, T.S., Perez, F.A., Scouras, A.D., Stoll, E.A., Gale, S.D., Luquet, S., … Palmiter, R.D. (2006). Cre recombinase-mediated restoration of nigrostriatal dopamine in dopamine-deficient mice reverses hypophagia and bradykinesia. Proceedings of the National Academy of Sciences of the United States of America, 103, 8858–8863. doi: 10.1073/pnas.0603081103
   PubMed Web of Science ®Google Scholar
• Holder, J.L., & Wilfong, A.A. (2011). Zonisamide in the treatment of epilepsy. Expert Opinion on Pharmacotherapy, 12, 2573–2581. doi: 10.1517/14656566.2011.622268
   PubMed Web of Science ®Google Scholar
• Hosenbocus, S., & Chahal, R. (2013). Memantine: A review of possible uses in child and adolescent psychiatry. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 22, 166–171. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23667364
   PubMedGoogle Scholar
• Hotta, M., Ohwada, R., Akamizu, T., Shibasaki, T., Takano, K., & Kangawa, K. (2009). Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: A pilot study. Endocrine Journal, 56, 1119–1128. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1975575310.1507/endocrj.K09E-168
   PubMed Web of Science ®Google Scholar
• Hudson, J.I., Lalonde, J.K., Berry, J.M., Pindyck, L.J., Bulik, C.M., Crow, S.J., … Pope, H.G. (2006). Binge-eating disorder as a distinct familial phenotype in obese individuals. Archives of General Psychiatry, 63, 313–319. doi: 10.1001/archpsyc.63.3.313
   PubMed Web of Science ®Google Scholar
• Jean, A., Conductier, G., Manrique, C., Bouras, C., Berta, P., Hen, R., … Compan, V. (2007). Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens. Proceedings of the National Academy of Sciences of the United States of America, 104, 16335–16340. doi: 10.1073/pnas.0701471104
   PubMed Web of Science ®Google Scholar
• Jennings, K.M., Wildes, J.E., & Coccaro, E.F. (2017). Intermittent explosive disorder and eating disorders: Analysis of national comorbidity and research samples. Comprehensive Psychiatry, 75, 62–67. doi: 10.1016/j.comppsych.2017.02.011
   PubMed Web of Science ®Google Scholar
• Jirtle, R.L., & Skinner, M.K. (2007). Environmental epigenomics and disease susceptibility. Nature Reviews. Genetics, 8, 253–262. doi: 10.1038/nrg2045
   PubMed Web of Science ®Google Scholar
• Kageyama, H., Takenoya, F., Shiba, K., & Shioda, S. (2010). Neuronal circuits involving ghrelin in the hypothalamus-mediated regulation of feeding. Neuropeptides, 44, 133–138. doi: 10.1016/j.npep.2009.11.010
   PubMed Web of Science ®Google Scholar
• Kalyanasundar, B., Perez, C.I., Luna, A., Solorio, J., Moreno, M.G., Elias, D., … Gutierrez, R. (2015). D1 and D2 antagonists reverse the effects of appetite suppressants on weight loss, food intake, locomotion, and rebalance spiking inhibition in the rat NAc shell. Journal of Neurophysiology, 114, 585–607. doi: 10.1152/jn.00012.2015
   PubMed Web of Science ®Google Scholar
• Kannan, K., & Fridell, Y.-W.C. (2013). Functional implications of Drosophila insulin-like peptides in metabolism, aging, and dietary restriction. Frontiers in Physiology, 4, 288. doi: 10.3389/fphys.2013.00288
   PubMed Web of Science ®Google Scholar
• Karra, E., Chandarana, K., & Batterham, R.L. (2009). The role of peptide YY in appetite regulation and obesity. Journal of Physiology, 587, 19–25. doi: 10.1113/jphysiol.2008.164269
   PubMed Web of Science ®Google Scholar
• Kawahara, Y., Kawahara, H., Kaneko, F., Yamada, M., Nishi, Y., Tanaka, E., & Nishi, A. (2009). Peripherally administered ghrelin induces bimodal effects on the mesolimbic dopamine system depending on food-consumptive states. Neuroscience, 161, 855–864. doi: 10.1016/j.neuroscience.2009.03.086
   PubMed Web of Science ®Google Scholar
• Kawai, K., Nakashima, M., Kojima, M., Yamashita, S., Takakura, S., Shimizu, M., … Sudo, N. (2017). Ghrelin activation and neuropeptide Y elevation in response to medium chain triglyceride administration in anorexia nervosa patients. Clinical Nutrition ESPEN, 17, 100–104. doi: 10.1016/j.clnesp.2016.10.001
   PubMedGoogle Scholar
• Kaye, W. (1997). Anorexia nervosa, obsessional behavior, and serotonin. Psychopharmacology Bulletin, 33, 335–344. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9550876
   PubMed Web of Science ®Google Scholar
• Kaye, W.H., Bailer, U.F., Frank, G.K., Wagner, A., & Henry, S.E. (2005). Brain imaging of serotonin after recovery from anorexia and bulimia nervosa. Physiology & Behavior, 86, 15–17. doi: 10.1016/j.physbeh.2005.06.019
   PubMed Web of Science ®Google Scholar
• Kaye, W.H., Fudge, J.L., & Paulus, M. (2009). New insights into symptoms and neurocircuit function of anorexia nervosa. Nature Reviews, Neuroscience, 10, 573–584. doi: 10.1038/nrn2682
   PubMed Web of Science ®Google Scholar
• Keller, P.A., Compan, V., Bockaert, J., Giacobino, J.-P., Charnay, Y., Bouras, C., & Assimacopoulos-Jeannet, F. (2006). Characterization and localization of cocaine- and amphetamine-regulated transcript (CART) binding sites. Peptides, 27, 1328–1334. doi: 10.1016/j.peptides.2005.10.016
   PubMed Web of Science ®Google Scholar
• Kern, A., Albarran-Zeckler, R., Walsh, H.E., & Smith, R.G. (2012). Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism. Neuron, 73, 317–332. doi:10.1016/j.neuron.2011.10.038
   Google Scholar
• Keski-Rahkonen, A., & Mustelin, L. (2016). Epidemiology of eating disorders in Europe: Prevalence, incidence, comorbidity, course, consequences, and risk factors. Current Opinion in Psychiatry, 29, 340–345. doi: 10.1097/YCO.0000000000000278
   PubMed Web of Science ®Google Scholar
• Kim, C., Kim, S., & Park, S. (2017). Neurogenic effects of ghrelin on the hippocampus. International Journal of Molecular Sciences, 18, 588. doi: 10.3390/ijms18030588
   Web of Science ®Google Scholar
• Kim, G., Deepinder, F., Morales, W., Hwang, L., Weitsman, S., Chang, C., … Pimentel, M. (2012). Methanobrevibacter smithii is the predominant methanogen in patients with constipation-predominant IBS and methane on breath. Digestive Diseases and Sciences, 57, 3213–3218. doi: 10.1007/s10620-012-2197-1
   PubMed Web of Science ®Google Scholar
• Kim, Y.-R., Eom, J.-S., Yang, J.-W., Kang, J., & Treasure, J. (2015). The impact of oxytocin on food intake and emotion recognition in patients with eating disorders: A double blind single dose within-subject cross-over design. PLoS One, 10, e0137514. doi: 10.1371/journal.pone.0137514
   PubMed Web of Science ®Google Scholar
• Kim, Y.-R., Kim, J.-H., Kim, C.-H., Shin, J.G., & Treasure, J. (2015). Association between the oxytocin receptor gene polymorphism (rs53576) and bulimia nervosa. European Eating Disorders Review, 23, 171–178. doi: 10.1002/erv.2354
   PubMed Web of Science ®Google Scholar
• Kirkpatrick, S.L., Goldberg, L.R., Yazdani, N., Babbs, R.K., Wu, J., Reed, E.R., … Bryant, C.D. (2017). Cytoplasmic FMR1-interacting protein 2 is a major genetic factor underlying binge eating. Biological Psychiatry, 81, 757–769. doi: 10.1016/j.biopsych.2016.10.021
   PubMed Web of Science ®Google Scholar
• Kirsz, K., & Zieba, D.A. (2011). Ghrelin-mediated appetite regulation in the central nervous system. Peptides, 32, 2256–2264. doi: 10.1016/j.peptides.2011.04.010
   PubMed Web of Science ®Google Scholar
• Klenerova, V., Sery, O., & Hynie, S. (2008). Corticotropin-releasing hormone receptor subtypes in the rat anterior pituitary after two types of restraint stress. Annals of the New York Academy of Sciences, 1148, 415–420. doi: 10.1196/annals.1410.043
   PubMed Web of Science ®Google Scholar
• Kojima, M., Hosoda, H., & Kangawa, K. (2001). Purification and distribution of ghrelin: The natural endogenous ligand for the growth hormone secretagogue receptor. Hormone Research, 56 Suppl 1, 93–97. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11786694.
   PubMedGoogle Scholar
• Kokare, D.M., Dandekar, M.P., Singru, P.S., Gupta, G.L., & Subhedar, N.K. (2010). Involvement of alpha-MSH in the social isolation induced anxiety- and depression-like behaviors in rat. Neuropharmacology, 58, 1009–1018. doi: 10.1016/j.neuropharm.2010.01.006
   PubMed Web of Science ®Google Scholar
• Koob, G.F., & Volkow, N.D. (2010). Neurocircuitry of addiction. Neuropsychopharmacology, 35, 217–238. doi: 10.1038/npp.2009.110
   PubMed Web of Science ®Google Scholar
• Koren, R., Duncan, A.E., Munn-Chernoff, M.A., Bucholz, K.K., Lynskey, M.T., Heath, A.C., & Agrawal, A. (2014). Preliminary evidence for the role of HTR2A variants in binge eating in young women. Psychiatric Genetics, 24, 28–33. doi: 10.1097/YPG.0000000000000014
   PubMed Web of Science ®Google Scholar
• Kornstein, S.G., Kunovac, J.L., Herman, B.K., & Culpepper, L. (2016). Recognizing binge-eating disorder in the clinical setting: A review of the literature. Primary Care Companion for CNS Disorders, 18. doi: 10.4088/PCC.15r01905
   PubMedGoogle Scholar
• Koyama, T., Nakajima, Y., Fujii, T., & Kawashima, K. (1999). Enhancement of cortical and hippocampal cholinergic neurotransmission through 5-HT1A receptor-mediated pathways by BAY x 3702 in freely moving rats. Neuroscience Letters, 265, 33–36. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1032719910.1016/S0304-3940(99)00200-1
   PubMed Web of Science ®Google Scholar
• Krajmalnik-Brown, R., Ilhan, Z.-E., Kang, D.-W., & DiBaise, J.K. (2012). Effects of gut microbes on nutrient absorption and energy regulation. Nutrition in Clinical Practice, 27, 201–214. doi: 10.1177/0884533611436116
   PubMed Web of Science ®Google Scholar
• Krashes, M.J., DasGupta, S., Vreede, A., White, B., Armstrong, J.D., & Waddell, S. (2009). A neural circuit mechanism integrating motivational state with memory expression in Drosophila. Cell, 139, 416–427. doi: 10.1016/j.cell.2009.08.035
   PubMed Web of Science ®Google Scholar
• Kutlu, S., Aydin, M., Alcin, E., Ozcan, M., Bakos, J., Jezova, D., & Yilmaz, B. (2010). Leptin modulates noradrenaline release in the paraventricular nucleus and plasma oxytocin levels in female rats: A microdialysis study. Brain Research, 1317, 87–91. doi: 10.1016/j.brainres.2009.12.044
   PubMed Web of Science ®Google Scholar
• Lambe, E.K., Fillman, S.G., Webster, M.J., & Shannon Weickert, C. (2011). Serotonin receptor expression in human prefrontal cortex: Balancing excitation and inhibition across postnatal development. PLoS One, 6, e22799. doi: 10.1371/journal.pone.0022799
   PubMed Web of Science ®Google Scholar
• Laque, A., Yu, S., Qualls-Creekmore, E., Gettys, S., Schwartzenburg, C., Bui, K., … Münzberg, H. (2015). Leptin modulates nutrient reward via inhibitory galanin action on orexin neurons. Molecular Metabolism, 4, 706–717. doi: 10.1016/j.molmet.2015.07.002
   PubMed Web of Science ®Google Scholar
• Legrand, R., Lucas, N., Breton, J., Azhar, S., do Rego, J.-C., Déchelotte, P., … Fetissov, S.O. (2016). Ghrelin treatment prevents development of activity based anorexia in mice. European Neuropsychopharmacology, 26, 948–958. doi: 10.1016/j.euroneuro.2016.03.010
   PubMed Web of Science ®Google Scholar
• Leinninger, G.M., Jo, Y.-H., Leshan, R.L., Louis, G.W., Yang, H., Barrera, J.G., … Myers, M.G. (2009). Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding. Cell Metabolism, 10, 89–98. doi: 10.1016/j.cmet.2009.06.011
   PubMed Web of Science ®Google Scholar
• Leitenberg, H., Rosen, J.C., Wolf, J., Vara, L.S., Detzer, M.J., & Srebnik, D. (1994). Comparison of cognitive–behavior therapy and desipramine in the treatment of bulimia nervosa. Behaviour Research and Therapy, 32, 37–45. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/813572110.1016/0005-7967(94)90082-5
   PubMed Web of Science ®Google Scholar
• Lenard, N.R., & Berthoud, H.-R. (2008). Central and peripheral regulation of food intake and physical activity: Pathways and genes. Obesity (Silver Spring, Md.), 16 Suppl 3, S11–S22. doi: 10.1038/oby.2008.511
   PubMed Web of Science ®Google Scholar
• Lenka, A., Arumugham, S.S., Christopher, R., & Pal, P.K. (2016). Genetic substrates of psychosis in patients with Parkinson’s disease: A critical review. Journal of the Neurological Sciences, 364, 33–41. doi: 10.1016/j.jns.2016.03.005
   PubMed Web of Science ®Google Scholar
• Lilenfeld, L.R.R., Ringham, R., Kalarchian, M.A., & Marcus, M.D. (2008). A family history study of binge-eating disorder. Comprehensive Psychiatry, 49, 247–254. doi: 10.1016/j.comppsych.2007.10.001
   PubMed Web of Science ®Google Scholar
• Liu, C., Plaçais, P.-Y., Yamagata, N., Pfeiffer, B.D., Aso, Y., Friedrich, A.B., … Tanimoto, H. (2012). A subset of dopamine neurons signals reward for odour memory in Drosophila. Nature, 488, 512–516. doi: 10.1038/nature11304
   PubMed Web of Science ®Google Scholar
• Liu, J., Garza, J.C., Truong, H.V., Henschel, J., Zhang, W., & Lu, X.-Y. (2007). The melanocortinergic pathway is rapidly recruited by emotional stress and contributes to stress-induced anorexia and anxiety-like behavior. Endocrinology, 148, 5531–5540. doi: 10.1210/en.2007-0745
   PubMed Web of Science ®Google Scholar
• Locke, A.E., Kahali, B., Berndt, S.I., Justice, A.E., Pers, T.H., Day, F.R., … Speliotes, E.K. (2015). Genetic studies of body mass index yield new insights for obesity biology. Nature, 518, 197–206. doi: 10.1038/nature14177
   PubMed Web of Science ®Google Scholar
• Louis, G.W., Leinninger, G.M., Rhodes, C.J., & Myers, M.G. (2010). Direct innervation and modulation of orexin neurons by lateral hypothalamic LepRb neurons. Journal of Neuroscience, 30, 11278–11287. doi: 10.1523/JNEUROSCI.1340-10.2010
   PubMed Web of Science ®Google Scholar
• Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., … Memish, Z.A. (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet (London, England), 380, 2095–2128. doi: 10.1016/S0140-6736(12)61728-0
   PubMed Web of Science ®Google Scholar
• Lutz, T.A., Senn, M., Althaus, J., Del Prete, E., Ehrensperger, F., & Scharrer, E. (1998). Lesion of the area postrema/nucleus of the solitary tract (AP/NTS) attenuates the anorectic effects of amylin and calcitonin gene-related peptide (CGRP) in rats. Peptides, 19, 309–317. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/949386310.1016/S0196-9781(97)00292-1
   PubMed Web of Science ®Google Scholar
• Maes, M., Monteleone, P., Bencivenga, R., Goossens, F., Maj, M., van West, D., … Scharpe, S. (2001). Lower serum activity of prolyl endopeptidase in anorexia and bulimia nervosa. Psychoneuroendocrinology, 26, 17–26. Retrieved from doi: http://www.ncbi.nlm.nih.gov/pubmed/11070331
   PubMed Web of Science ®Google Scholar
• Mahler, S.V., Smith, K.S., & Berridge, K.C. (2007). Endocannabinoid hedonic hotspot for sensory pleasure: Anandamide in nucleus accumbens shell enhances “liking” of a sweet reward. Neuropsychopharmacology, 32, 2267–2278. doi: 10.1038/sj.npp.1301376
   PubMed Web of Science ®Google Scholar
• Martiadis, V., Castaldo, E., Monteleone, P., & Maj, M. (2007). The role of psychopharmacology in the treatment of eating disorders. Clinical Neuropsychiatry, 4, 51–60.
   Google Scholar
• Martinussen, M., Friborg, O., Schmierer, P., Kaiser, S., Øvergård, K.T., Neunhoeffer, A.-L., … Rosenvinge, J.H. (2016). The comorbidity of personality disorders in eating disorders: A meta-analysis. Eating and Weight Disorders, 22, 201–209. doi: 10.1007/s40519-016-0345-x
   PubMed Web of Science ®Google Scholar
• McElroy, S., Guerdjikova, A.I., Mori, N., & O’melia, A. (2012). Pharmacological management of binge eating disorder: Current and emerging treatment options. Therapeutics and Clinical Risk Management, 8, 219–241. doi: 10.2147/TCRM.S25574
   PubMed Web of Science ®Google Scholar
• McElroy, S.L., Guerdjikova, A.I., Martens, B., Keck, P.E., Pope, H.G., & Hudson, J.I. (2009). Role of antiepileptic drugs in the management of eating disorders. CNS Drugs, 23, 139–156. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1917337310.2165/00023210-200923020-00004
   PubMed Web of Science ®Google Scholar
• McElroy, S.L., Guerdjikova, A., Kotwal, R., Welge, J.A., Nelson, E.B., Lake, K.A., … Hudson, J.I. (2007). Atomoxetine in the treatment of binge-eating disorder: A randomized placebo-controlled trial. Journal of Clinical Psychiatry, 68 (3), 390–8. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17388708
   PubMed Web of Science ®Google Scholar
• McElroy, S.L., Hudson, J.I., Malhotra, S., Welge, J.A., Nelson, E.B., & Keck, P.E. (2003). Citalopram in the treatment of binge-eating disorder: A placebo-controlled trial. Journal of Clinical Psychiatry, 64, 807–813. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1293498210.4088/JCP.v64n0711
   PubMed Web of Science ®Google Scholar
• McGuirk, J., Goodall, E., Silverstone, T., & Willner, P. (1991). Differential effects of d-fenfluramine, l-fenfluramine and d-amphetamine on the microstructure of human eating behaviour. Behavioural Pharmacology, 2, 113–119. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1122405510.1097/00008877-199104000-00004
   PubMed Web of Science ®Google Scholar
• McKnight, R.F., & Park, R.J. (2010). Atypical antipsychotics and anorexia nervosa: A review. European Eating Disorders Review, 18, 10–21. doi: 10.1002/erv.988
   PubMed Web of Science ®Google Scholar
• Meister, B. (2007). Neurotransmitters in key neurons of the hypothalamus that regulate feeding behavior and body weight. Physiology & Behavior, 92, 263–271.doi: 10.1016/j.physbeh.2007.05.021
   PubMed Web of Science ®Google Scholar
• Melcher, C., & Pankratz, M.J. (2005). Candidate gustatory interneurons modulating feeding behavior in the Drosophila brain. PLoS Biology, 3, e305. doi: 10.1371/journal.pbio.0030305
   PubMed Web of Science ®Google Scholar
• Micioni Di Bonaventura, M.V., Ciccocioppo, R., Romano, A., Bossert, J.M., Rice, K.C., Ubaldi, M., … Cifani, C. (2014). Role of bed nucleus of the stria terminalis corticotrophin-releasing factor receptors in frustration stress-induced binge-like palatable food consumption in female rats with a history of food restriction. Journal of Neuroscience, 34, 11316–11324. doi: 10.1523/JNEUROSCI.1854-14.2014
   PubMed Web of Science ®Google Scholar
• Milano, W., Petrella, C., Casella, A., Capasso, A., Carrino, S., & Milano, L. (2005). Use of sibutramine, an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: A placebo-controlled study. Advances in Therapy, 22, 25–31. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1594321910.1007/BF02850181
   PubMed Web of Science ®Google Scholar
• Milano, W., Petrella, C., Sabatino, C., & Capasso, A. (2004). Treatment of bulimia nervosa with sertraline: A randomized controlled trial. Advances in Therapy, 21, 232–237. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1560561710.1007/BF02850155
   PubMed Web of Science ®Google Scholar
• Miljic, D., Pekic, S., Djurovic, M., Doknic, M., Milic, N., Casanueva, F.F., … Popovic, V. (2006). Ghrelin has partial or no effect on appetite, growth hormone, prolactin, and cortisol release in patients with anorexia nervosa. Journal of Clinical Endocrinology and Metabolism, 91, 1491–1495. doi: 10.1210/jc.2005-2304
   PubMed Web of Science ®Google Scholar
• Miller, R. (2009). Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: PART II. Current Neuropharmacology, 7, 315–330. doi: 10.2174/157015909790031184
   PubMed Web of Science ®Google Scholar
• Millington, G.W. (2007). The role of proopiomelanocortin (POMC) neurones in feeding behaviour. Nutrition & Metabolism, 4, 18. doi: 10.1186/1743-7075-4-18
   PubMed Web of Science ®Google Scholar
• Mineur, Y.S., Einstein, E.B., Bentham, M.P., Wigestrand, M.B., Blakeman, S., Newbold, S.A., & Picciotto, M.R. (2015). Expression of the 5-HT1A serotonin receptor in the hippocampus is required for social stress resilience and the antidepressant-like effects induced by the nicotinic partial agonist cytisine. Neuropsychopharmacology, 40, 938–946. doi: 10.1038/npp.2014.269
   PubMed Web of Science ®Google Scholar
• Mischoulon, D., Eddy, K.T., Keshaviah, A., Dinescu, D., Ross, S.L., Kass, A.E., … Herzog, D.B. (2011). Depression and eating disorders: Treatment and course. Journal of Affective Disorders, 130, 470–477. doi: 10.1016/j.jad.2010.10.043
   PubMed Web of Science ®Google Scholar
• Mithieux, G. (2013). Nutrient control of hunger by extrinsic gastrointestinal neurons. Trends in Endocrinology and Metabolism, 24, 378–384. doi: 10.1016/j.tem.2013.04.005
   PubMed Web of Science ®Google Scholar
• Monteleone, A.M., Scognamiglio, P., Volpe, U., Di Maso, V., & Monteleone, P. (2016). Investigation of oxytocin secretion in anorexia nervosa and bulimia nervosa: Relationships to temperament personality dimensions. European Eating Disorders Review, 24, 52–56. doi: 10.1002/erv.2391
   PubMed Web of Science ®Google Scholar
• Monteleone, P., Castaldo, E., & Maj, M. (2008). Neuroendocrine dysregulation of food intake in eating disorders. Regulatory Peptides, 149, 39–50. doi: 10.1016/j.regpep.2007.10.007
   PubMedGoogle Scholar
• Monteleone, P., Fabrazzo, M., Tortorella, A., Fuschino, A., & Maj, M. (2002). Opposite modifications in circulating leptin and soluble leptin receptor across the eating disorder spectrum. Molecular Psychiatry, 7, 641–646. doi: 10.1038/sj.mp.4001043
   PubMed Web of Science ®Google Scholar
• Morton, G.J., Cummings, D.E., Baskin, D.G., Barsh, G.S., & Schwartz, M.W. (2006). Central nervous system control of food intake and body weight. Nature, 443, 289–295. doi: 10.1038/nature05026
   PubMed Web of Science ®Google Scholar
• Munn-Chernoff, M.A., & Baker, J.H. (2016). A primer on the genetics of comorbid eating disorders and substance use disorders. European Eating Disorders Review, 24, 91–100. doi: 10.1002/erv.2424
   PubMed Web of Science ®Google Scholar
• Munn-Chernoff, M.A., Grant, J.D., Bucholz, K.K., Agrawal, A., Lynskey, M.T., Madden, P.A.F., … Duncan, A.E. (2015). Bulimic behaviors and early substance use: Findings from a Cotwin-control study. Alcoholism, Clinical and Experimental Research, 39, 1740–1748. doi: 10.1111/acer.12829
   PubMed Web of Science ®Google Scholar
• Muroya, S., Funahashi, H., Yamanaka, A., Kohno, D., Uramura, K., Nambu, T., … Yada, T. (2004). Orexins (hypocretins) directly interact with neuropeptide Y, POMC and glucose-responsive neurons to regulate Ca 2+ signaling in a reciprocal manner to leptin: orexigenic neuronal pathways in the mediobasal hypothalamus. European Journal of Neuroscience, 19, 1524–1534. doi: 10.1111/j.1460-9568.2004.03255.x
   PubMed Web of Science ®Google Scholar
• Murphy, K.G. (2005). Dissecting the role of cocaine- and amphetamine-regulated transcript (CART) in the control of appetite. Briefings in Functional Genomics & Proteomics, 4, 95–111. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1610226710.1093/bfgp/4.2.95
   PubMedGoogle Scholar
• Murray, C.J.L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A.D., Michaud, C., … Memish, Z.A. (2012). Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet (London, England), 380, 2197–2223. doi: 10.1016/S0140-6736(12)61689-4
   PubMed Web of Science ®Google Scholar
• Nagamitsu, S., Araki, Y., Ioji, T., Yamashita, F., Ozono, S., Kouno, M., … Matsuishi, T. (2011). Prefrontal brain function in children with anorexia nervosa: A near-infrared spectroscopy study. Brain & Development, 33, 35–44. doi: 10.1016/j.braindev.2009.12.010
   PubMed Web of Science ®Google Scholar
• Nakabayashi, M., Suzuki, T., Takahashi, K., Totsune, K., Muramatsu, Y., Kaneko, C., … Sasano, H. (2003). Orexin-A expression in human peripheral tissues. Molecular and Cellular Endocrinology, 205, 43–50. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12890566
   PubMed Web of Science ®Google Scholar
• Nakai, Y., Hosoda, H., Nin, K., Ooya, C., Hayashi, H., Akamizu, T., & Kangawa, K. (2003). Plasma levels of active form of ghrelin during oral glucose tolerance test in patients with anorexia nervosa. European Journal of Endocrinology, 149, R1–R3. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1282486910.1530/eje.0.149R001
   PubMed Web of Science ®Google Scholar
• Naleid, A.M., Grace, M.K., Chimukangara, M., Billington, C.J., & Levine, A.S. (2007). Paraventricular opioids alter intake of high-fat but not high-sucrose diet depending on diet preference in a binge model of feeding. American Journal of Physiology, Regulatory, Integrative and Comparative Physiology, 293, R99–105. doi: 10.1152/ajpregu.00675.2006
   PubMed Web of Science ®Google Scholar
• Nässel, D.R., & Winther, A.M.E. (2010). Drosophila neuropeptides in regulation of physiology and behavior. Progress in Neurobiology, 92, 42–104. doi: 10.1016/j.pneurobio.2010.04.010
   PubMed Web of Science ®Google Scholar
• Nickel, C., Tritt, K., Muehlbacher, M., Pedrosa Gil, F., Mitterlehner, F.O., Kaplan, P., … Nickel, M.K. (2005). Topiramate treatment in bulimia nervosa patients: A randomized, double-blind, placebo-controlled trial. International Journal of Eating Disorders, 38, 295–300. doi: 10.1002/eat.20202
   PubMed Web of Science ®Google Scholar
• O’Brien, K.M., & Vincent, N.K. (2003). Psychiatric comorbidity in anorexia and bulimia nervosa: Nature, prevalence, and causal relationships. Clinical Psychology Review, 23, 57–74. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12559994
   PubMed Web of Science ®Google Scholar
• Okita, K., Shiina, A., Nakazato, M., & Iyo, M. (2013). Tandospirone, a 5-HT1A partial agonist is effective in treating anorexia nervosa: A case series. Annals of General Psychiatry, 12, 7. doi: 10.1186/1744-859X-12-7
   PubMed Web of Science ®Google Scholar
• Oldershaw, A., Hambrook, D., Stahl, D., Tchanturia, K., Treasure, J., & Schmidt, U. (2011). The socio-emotional processing stream in Anorexia Nervosa. Neuroscience and Biobehavioral Reviews, 35, 970–988. doi: 10.1016/j.neubiorev.2010.11.001
   PubMed Web of Science ®Google Scholar
• Otto, B., Cuntz, U., Fruehauf, E., Wawarta, R., Folwaczny, C., Riepl, R.L., … Tschöp, M. (2001). Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. European Journal of Endocrinology, 145, 669–673. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11720888
   PubMed Web of Science ®Google Scholar
• Padwal, R.S., & Majumdar, S.R. (2007). Drug treatments for obesity: Orlistat, sibutramine, and rimonabant. Lancet (London, England), 369, 71–77. doi: 10.1016/S0140-6736(07)60033-6
   PubMed Web of Science ®Google Scholar
• Pandit, R., la Fleur, S.E., & Adan, R.A.H. (2013). The role of melanocortins and Neuropeptide Y in food reward. European Journal of Pharmacology, 719, 208–214. doi: 10.1016/j.ejphar.2013.04.059
   PubMed Web of Science ®Google Scholar
• Park, J.-H., Shim, H.-M., Na, A.-Y., Bae, J.-H., Im, S.-S., & Song, D.-K. (2015). Orexin A regulates plasma insulin and leptin levels in a time-dependent manner following a glucose load in mice. Diabetologia, 58, 1542–1550. doi: 10.1007/s00125-015-3573-0
   PubMed Web of Science ®Google Scholar
• Pelchat, M.L. (2009). Food addiction in humans. Journal of Nutrition, 139, 620–622. doi: 10.3945/jn.108.097816
   PubMed Web of Science ®Google Scholar
• Perello, M., & Dickson, S.L. (2015). Ghrelin signalling on food reward: A salient link between the gut and the mesolimbic system. Journal of Neuroendocrinology, 27, 424–434. doi: 10.1111/jne.12236
   PubMed Web of Science ®Google Scholar
• Perello, M., Scott, M.M., Sakata, I., Lee, C.E., Chuang, J.-C., Osborne-Lawrence, S., … Zigman, J.M. (2012). Functional implications of limited leptin receptor and ghrelin receptor coexpression in the brain. Journal of Comparative Neurology, 520, 281–294. doi: 10.1002/cne.22690
   PubMed Web of Science ®Google Scholar
• Peters, S.T., Bowen, M.T., Bohrer, K., McGregor, I.S., & Neumann, I.D. (2017). Oxytocin inhibits ethanol consumption and ethanol-induced dopamine release in the nucleus accumbens. Addiction Biology, 22, 702–711. doi: 10.1111/adb.12362
   PubMed Web of Science ®Google Scholar
• Pjetri, E., Schmidt, U., Kas, M.J., & Campbell, I.C. (2012). Epigenetics and eating disorders. Current Opinion in Clinical Nutrition and Metabolic Care, 15, 330–335. doi: 10.1097/MCO.0b013e3283546fd3
   PubMed Web of Science ®Google Scholar
• Pool, A.-H., & Scott, K. (2014). Feeding regulation in Drosophila. Current Opinion in Neurobiology, 29, 57–63. doi: 10.1016/j.conb.2014.05.008
   PubMed Web of Science ®Google Scholar
• Popik, P., Kos, T., Zhang, Y., & Bisaga, A. (2011). Memantine reduces consumption of highly palatable food in a rat model of binge eating. Amino Acids, 40, 477–485. doi: 10.1007/s00726-010-0659-3
   PubMed Web of Science ®Google Scholar
• Powers, P.S., & Bruty, H. (2009). Pharmacotherapy for eating disorders and obesity. Child and Adolescent Psychiatric Clinics of North America, 18, 175–187. doi: 10.1016/j.chc.2008.07.009
   PubMed Web of Science ®Google Scholar
• Powers, P.S., & Santana, C. (2004). Available pharmacological treatments for anorexia nervosa. Expert Opinion on Pharmacotherapy, 5, 2287–2292. doi: 10.1517/14656566.5.11.2287
   PubMed Web of Science ®Google Scholar
• Preti, A., Girolamo, G., de Vilagut, G., Alonso, J., Graaf, R., de Bruffaerts, R. … ESEMeD-WMH Investigators. (2009). The epidemiology of eating disorders in six European countries: Results of the ESEMeD-WMH project. Journal of Psychiatric Research, 43, 1125–1132. doi: 10.1016/j.jpsychires.2009.04.003
   PubMed Web of Science ®Google Scholar
• Rada, P., Avena, N.M., & Hoebel, B.G. (2005). Daily bingeing on sugar repeatedly releases dopamine in the accumbens shell. Neuroscience, 134, 737–744. doi: 10.1016/j.neuroscience.2005.04.043
   PubMed Web of Science ®Google Scholar
• Rasmusson, A.M., Goldstein, L.E., Deutch, A.Y., Bunney, B.S., & Roth, R.H. (1994). 5-HT1a agonist +/−8-OH-DPAT modulates basal and stress-induced changes in medial prefrontal cortical dopamine. Synapse (New York, N.Y.), 18, 218–224. doi: 10.1002/syn.890180307
   PubMed Web of Science ®Google Scholar
• Reas, D.L., & Grilo, C.M. (2008). Review and meta-analysis of pharmacotherapy for binge-eating disorder. Obesity (Silver Spring, Md.), 16, 2024–2038. doi: 10.1038/oby.2008.333
   PubMed Web of Science ®Google Scholar
• Ricca, V., Castellini, G., Lo Sauro, C., Rotella, C.M., & Faravelli, C. (2009). Zonisamide combined with cognitive behavioral therapy in binge eating disorder: A one-year follow-up study. Psychiatry (Edgmont (Pa.: Township)), 6, 23–28. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20049147
   PubMedGoogle Scholar
• Richard, J.E., Farkas, I., Anesten, F., Anderberg, R.H., Dickson, S.L., Gribble, F.M., … Skibicka, K.P. (2014). GLP-1 receptor stimulation of the lateral parabrachial nucleus reduces food intake: Neuroanatomical, electrophysiological, and behavioral evidence. Endocrinology, 155, 4356–4367. doi: 10.1210/en.2014-1248
   PubMed Web of Science ®Google Scholar
• Rindi, G., Necchi, V., Savio, A., Torsello, A., Zoli, M., Locatelli, V., … Solcia, E. (2002). Characterisation of gastric ghrelin cells in man and other mammals: Studies in adult and fetal tissues. Histochemistry and Cell Biology, 117, 511–519. doi: 10.1007/s00418-002-0415-1
   PubMed Web of Science ®Google Scholar
• Romano, S.J., Halmi, K.A., Sarkar, N.P., Koke, S.C., & Lee, J.S. (2002). A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment. American Journal of Psychiatry, 159, 96–102. doi: 10.1176/appi.ajp.159.1.96
   PubMed Web of Science ®Google Scholar
• Root, T.L., Szatkiewicz, J.P., Jonassaint, C.R., Thornton, L.M., Pinheiro, A.P., Strober, M., … Bulik, C.M. (2011). Association of candidate genes with phenotypic traits relevant to anorexia nervosa. European Eating Disorders Review, 19, 487–493. doi: 10.1002/erv.1138
   PubMed Web of Science ®Google Scholar
• Ross, H.E., & Young, L.J. (2009). Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior. Frontiers in Neuroendocrinology, 30, 534–547. doi: 10.1016/j.yfrne.2009.05.004
   PubMed Web of Science ®Google Scholar
• Rothman, R.B., & Baumann, M.H. (2002). Therapeutic and adverse actions of serotonin transporter substrates. Pharmacology & Therapeutics, 95, 73–88. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1216312910.1016/S0163-7258(02)00234-6
   PubMed Web of Science ®Google Scholar
• Routtenberg, A., & Kuznesof, A.W. (1967). Self-starvation of rats living in activity wheels on a restricted feeding schedule. Journal of Comparative and Physiological Psychology, 64, 414–421. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/608287310.1037/h0025205
   PubMed Web of Science ®Google Scholar
• Ryan, K.K., Mul, J.D., Clemmensen, C., Egan, A.E., Begg, D.P., Halcomb, K., … Ulrich-Lai, Y.M. (2014). Loss of melanocortin-4 receptor function attenuates HPA responses to psychological stress. Psychoneuroendocrinology, 42, 98–105. doi: 10.1016/j.psyneuen.2014.01.010
   PubMed Web of Science ®Google Scholar
• Saffrey, R., Novakovic, B., & Wade, T.D. (2014). Assessing global and gene specific DNA methylation in anorexia nervosa: A pilot study. International Journal of Eating Disorders, 47, 206–210. doi: 10.1002/eat.22200
   PubMed Web of Science ®Google Scholar
• Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R.M., Tanaka, H., … Yanagisawa, M. (1998). Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell, 92, 573–585. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9491897
   PubMed Web of Science ®Google Scholar
• Samnaliev, M., Noh, H.L., Sonneville, K.R., & Austin, S.B. (2015). The economic burden of eating disorders and related mental health comorbidities: An exploratory analysis using the U.S. Medical Expenditures Panel Survey. Preventive Medicine Reports, 2, 32–34. doi: 10.1016/j.pmedr.2014.12.002
   PubMedGoogle Scholar
• Saper, C.B., Chou, T.C., & Elmquist, J.K. (2002). The need to feed: Homeostatic and hedonic control of eating. Neuron, 36, 199–211. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1238377710.1016/S0896-6273(02)00969-8
   PubMed Web of Science ®Google Scholar
• Schwartz, M.W., Baskin, D.G., Bukowski, T.R., Kuijper, J.L., Foster, D., Lasser, G., … Weigle, D.S. (1996). Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes, 45, 531–535. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8603777
   PubMed Web of Science ®Google Scholar
• Schwartz, T.L., Siddiqui, U.A., & Raza, S. (2012). Memantine as an augmentation therapy for anxiety disorders. Case Reports in Psychiatry, 2012, 749796. doi: 10.1155/2012/749796
   PubMedGoogle Scholar
• Scott-Van Zeeland, A.A., Bloss, C.S., Tewhey, R., Bansal, V., Torkamani, A., Libiger, O., … Schork, N. J. (2014). Evidence for the role of EPHX2 gene variants in anorexia nervosa. Molecular Psychiatry, 19, 724–732. doi: 10.1038/mp.2013.91
   PubMed Web of Science ®Google Scholar
• Sedlackova, D., Kopeckova, J., Papezova, H., Hainer, V., Kvasnickova, H., Hill, M., & Nedvidkova, J. (2012). Comparison of a high-carbohydrate and high-protein breakfast effect on plasma ghrelin, obestatin, NPY and PYY levels in women with anorexia and bulimia nervosa. Nutrition & Metabolism, 9, 52. doi: 10.1186/1743-7075-9-52
   PubMed Web of Science ®Google Scholar
• Shah, M., & Vella, A. (2014). Effects of GLP-1 on appetite and weight. Reviews in Endocrine & Metabolic Disorders, 15, 181–187. doi: 10.1007/s11154-014-9289-5
   PubMed Web of Science ®Google Scholar
• Shank, R.P., & Maryanoff, B.E. (2008). Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate. CNS Neuroscience & Therapeutics, 14, 120–142. doi: 10.1111/j.1527-3458.2008.00041.x
   PubMed Web of Science ®Google Scholar
• Skibicka, K.P., Shirazi, R.H., Rabasa-Papio, C., Alvarez-Crespo, M., Neuber, C., Vogel, H., & Dickson, S.L. (2013). Divergent circuitry underlying food reward and intake effects of ghrelin: Dopaminergic VTA-accumbens projection mediates ghrelin’s effect on food reward but not food intake. Neuropharmacology, 73, 274–283. doi: 10.1016/j.neuropharm.2013.06.004
   PubMed Web of Science ®Google Scholar
• Smith, D., Dempster, C., Glanville, J., Freemantle, N., & Anderson, I. (2002). Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: A meta-analysis. British Journal of Psychiatry, 180, 396–404. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1198363510.1192/bjp.180.5.396
   PubMed Web of Science ®Google Scholar
• Smith, K.L., Rao, R.R., Velázquez-Sánchez, C., Valenza, M., Giuliano, C., Everitt, B.J., … Cottone, P. (2015). The uncompetitive N-methyl-D-aspartate antagonist memantine reduces binge-like eating, food-seeking behavior, and compulsive eating: Role of the nucleus accumbens shell. Neuropsychopharmacology, 40, 1163–1171. doi: 10.1038/npp.2014.299
   PubMed Web of Science ®Google Scholar
• Smitka, K., Papezova, H., Vondra, K., Hill, M., Hainer, V., & Nedvidkova, J. (2013). The role of “mixed” orexigenic and anorexigenic signals and autoantibodies reacting with appetite-regulating neuropeptides and peptides of the adipose tissue-gut-brain axis: Relevance to food intake and nutritional status in patients with anorexia nervosa. International Journal of Endocrinology, 2013, 483145. doi: 10.1155/2013/483145
   PubMed Web of Science ®Google Scholar
• Söderberg, J.A.E., Carlsson, M.A., & Nässel, D.R. (2012). Insulin-producing cells in the drosophila brain also express satiety-inducing cholecystokinin-like peptide, drosulfakinin. Frontiers in Endocrinology, 3, 109. doi: 10.3389/fendo.2012.00109
   PubMedGoogle Scholar
• Soria-Gomez, E., Bellocchio, L., & Marsicano, G. (2014). New insights on food intake control by olfactory processes: The emerging role of the endocannabinoid system. Molecular and Cellular Endocrinology, 397, 59–66. doi: 10.1016/j.mce.2014.09.023
   PubMed Web of Science ®Google Scholar
• Stanley, B.G., Kyrkouli, S.E., Lampert, S., & Leibowitz, S.F. (1986). Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity. Peptides, 7, 1189–1192. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/347071110.1016/0196-9781(86)90149-X
   PubMed Web of Science ®Google Scholar
• Stefano, S.C., Bacaltchuk, J., Blay, S.L., & Appolinário, J.C. (2008). Antidepressants in short-term treatment of binge eating disorder: Systematic review and meta-analysis. Eating Behaviors, 9, 129–136. doi: 10.1016/j.eatbeh.2007.03.006
   PubMedGoogle Scholar
• Steiger, H., Labonté, B., Groleau, P., Turecki, G., & Israel, M. (2013). Methylation of the glucocorticoid receptor gene promoter in bulimic women: Associations with borderline personality disorder, suicidality, and exposure to childhood abuse. International Journal of Eating Disorders, 46, 246–255. doi: 10.1002/eat.22113
   PubMed Web of Science ®Google Scholar
• Steiger, H., & Thaler, L. (2016). Eating disorders, gene-environment interactions and the epigenome: Roles of stress exposures and nutritional status. Physiology & Behavior, 162, 181–185. doi: 10.1016/j.physbeh.2016.01.041
   PubMed Web of Science ®Google Scholar
• Strober, M., Peris, T., & Steiger, H. (2014). The plasticity of development: How knowledge of epigenetics may advance understanding of eating disorders. International Journal of Eating Disorders, 47, 696–704. doi: 10.1002/eat.22322
   PubMed Web of Science ®Google Scholar
• Stunkard, A., Berkowitz, R., Tanrikut, C., Reiss, E., & Young, L. (1996). d-Fenfluramine treatment of binge eating disorder. American Journal of Psychiatry, 153, 1455–1459. doi: 10.1176/ajp.153.11.1455
   PubMed Web of Science ®Google Scholar
• Suh, J.J., Pettinati, H.M., Kampman, K.M., & O’brien, C.P. (2006). The status of disulfiram. A half of a century later. Journal of Clinical Psychopharmacology, 26, 290–302. doi: 10.1097/01.jcp.0000222512.25649.08
   PubMed Web of Science ®Google Scholar
• Sumiyoshi, T., Higuchi, Y., Matsui, M., Arai, H., Takamiya, C., Meltzer, H.Y., & Kurachi, M. (2007). Effective adjunctive use of tandospirone with perospirone for enhancing verbal memory and quality of life in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 31, 965–967. doi: 10.1016/j.pnpbp.2007.02.017
   PubMed Web of Science ®Google Scholar
• Sumiyoshi, T., Kunugi, H., & Nakagome, K. (2014). Serotonin and dopamine receptors in motivational and cognitive disturbances of schizophrenia. Frontiers in Neuroscience, 8, 395. doi: 10.3389/fnins.2014.00395
   PubMed Web of Science ®Google Scholar
• Taghert, P.H., & Nitabach, M.N. (2012). Peptide neuromodulation in invertebrate model systems. Neuron, 76, 82–97. doi: 10.1016/j.neuron.2012.08.035
   PubMed Web of Science ®Google Scholar
• Tanaka, H., Tatsuno, T., Shimizu, H., Hirose, A., Kumasaka, Y., & Nakamura, M. (1995). Effects of tandospirone on second messenger systems and neurotransmitter release in the rat brain. General Pharmacology, 26, 1765–1772. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/874516710.1016/0306-3623(95)00077-1
   PubMedGoogle Scholar
• Tennoune, N., Chan, P., Breton, J., Legrand, R., Chabane, Y.N., Akkermann, K., … Fetissov, S.O. (2014). Bacterial ClpB heat-shock protein, an antigen-mimetic of the anorexigenic peptide α-MSH, at the origin of eating disorders. Translational Psychiatry, 4, e458. doi: 10.1038/tp.2014.98
   PubMed Web of Science ®Google Scholar
• Thaler, L., Gauvin, L., Joober, R., Groleau, P., de Guzman, R., Ambalavanan, A., … Steiger, H. (2014). Methylation of BDNF in women with bulimic eating syndromes: Associations with childhood abuse and borderline personality disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 54, 43–49. doi: 10.1016/j.pnpbp.2014.04.010
   PubMed Web of Science ®Google Scholar
• Thornton, L.M., Mazzeo, S.E., & Bulik, C.M. (2011). The heritability of eating disorders: Methods and current findings. Current Topics in Behavioral Neurosciences, 6, 141–156. doi: 10.1007/7854_2010_91
   PubMedGoogle Scholar
• Tolle, V., Kadem, M., Bluet-Pajot, M.-T., Frere, D., Foulon, C., Bossu, C., … Estour, B. (2003). Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women. Journal of Clinical Endocrinology and Metabolism, 88, 109–116. doi: 10.1210/jc.2002-020645
   PubMed Web of Science ®Google Scholar
• Tomasik, P.J., Sztefko, K., & Starzyk, J. (2004). Cholecystokinin, glucose dependent insulinotropic peptide and glucagon-like peptide 1 secretion in children with anorexia nervosa and simple obesity. Journal of Pediatric Endocrinology & Metabolism, 17, 1623–1631. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1564569610.1515/JPEM.2004.17.12.1623
   PubMed Web of Science ®Google Scholar
• Tomasik, P.J., Sztefko, K., Starzyk, J., Rogatko, I., & Szafran, Z. (2005). Entero-insular axis in children with anorexia nervosa. Psychoneuroendocrinology, 30, 364–372. doi: 10.1016/j.psyneuen.2004.10.003
   PubMed Web of Science ®Google Scholar
• Treasure, J., Zipfel, S., Micali, N., Wade, T., Stice, E., Claudino, A., … Wentz, E. (2015). Anorexia nervosa. Nature Reviews. Disease Primers, 1, 15074. doi: 10.1038/nrdp.2015.74
   PubMed Web of Science ®Google Scholar
• Tremolizzo, L., Conti, E., Bomba, M., Uccellini, O., Rossi, M.S., Marfone, M., … Nacinovich, R. (2014). Decreased whole-blood global DNA methylation is related to serum hormones in anorexia nervosa adolescents. World Journal of Biological Psychiatry, 15, 327–333. doi: 10.3109/15622975.2013.860467
   PubMed Web of Science ®Google Scholar
• Uher, R., Murphy, T., Brammer, M.J., Dalgleish, T., Phillips, M.L., Ng, V.W., … Treasure, J. (2004). Medial prefrontal cortex activity associated with symptom provocation in eating disorders. American Journal of Psychiatry, 161, 1238–1246. doi: 10.1176/appi.ajp.161.7.1238
   PubMed Web of Science ®Google Scholar
• Umberg, E.N., Shader, R.I., Hsu, L.K.G., & Greenblatt, D.J. (2012). From disordered eating to addiction: The “food drug”. in Bulimia Nervosa. Journal of Clinical Psychopharmacology, 32, 376–389. doi: 10.1097/JCP.0b013e318252464f
   PubMed Web of Science ®Google Scholar
• van den Pol, A.N. (2012). Neuropeptide transmission in brain circuits. Neuron, 76, 98–115. doi: 10.1016/j.neuron.2012.09.014
   PubMed Web of Science ®Google Scholar
• Vandereycken, W. (1984). Neuroleptics in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled study with sulpiride. British Journal of Psychiatry, 144, 288–292. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/636787610.1192/bjp.144.3.288
   PubMed Web of Science ®Google Scholar
• Velligan, D.I., Alphs, L., Lancaster, S., Morlock, R., & Mintz, J. (2009). Association between changes on the negative symptom assessment scale (NSA-16) and measures of functional outcome in schizophrenia. Psychiatry Research, 169, 97–100. doi: 10.1016/j.psychres.2008.10.009
   PubMed Web of Science ®Google Scholar
• Volkow, N.D., Wang, G.-J., & Baler, R.D. (2011). Reward, dopamine and the control of food intake: Implications for obesity. Trends in Cognitive Sciences, 15, 37–46. doi: 10.1016/j.tics.2010.11.001
   PubMed Web of Science ®Google Scholar
• Wade, T.D., Gordon, S., Medland, S., Bulik, C.M., Heath, A.C., Montgomery, G.W., & Martin, N.G. (2013). Genetic variants associated with disordered eating. The International Journal of Eating Disorders, 46, 594–608. doi: 10.1002/eat.22133
   PubMed Web of Science ®Google Scholar
• Walsh, B.T., Hadigan, C.M., Devlin, M.J., Gladis, M., & Roose, S.P. (1991). Long-term outcome of antidepressant treatment for bulimia nervosa. American Journal of Psychiatry, 148, 1206–1212. doi: 10.1176/ajp.148.9.1206
   PubMed Web of Science ®Google Scholar
• Walsh, B.T., Kaplan, A.S., Attia, E., Olmsted, M., Parides, M., Carter, J.C., … Rockert, W. (2006). Fluoxetine after weight restoration in anorexia nervosa: A randomized controlled trial. JAMA, 295, 2605–2612. doi: 10.1001/jama.295.22.2605
   PubMed Web of Science ®Google Scholar
• Wang, K., Zhang, H., Bloss, C.S., Duvvuri, V., Kaye, W., Schork, N.J. … Price Foundation Collaborative Group. (2011). A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa. Molecular Psychiatry, 16, 949–959. doi: 10.1038/mp.2010.107
   PubMed Web of Science ®Google Scholar
• Williams, D.L., Cummings, D.E., Grill, H.J., & Kaplan, J.M. (2003). Meal-related ghrelin suppression requires postgastric feedback. Endocrinology, 144, 2765–2767. doi: 10.1210/en.2003-0381
   PubMed Web of Science ®Google Scholar
• Woods, S.C., Seeley, R.J., Porte, D., & Schwartz, M.W. (1998). Signals that regulate food intake and energy homeostasis. Science (New York, N.Y.), 280, 1378–1383. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/960372110.1126/science.280.5368.1378
   PubMed Web of Science ®Google Scholar
• Woodside, B.D., & Staab, R. (2006). Management of psychiatric comorbidity in anorexia nervosa and bulimia nervosa. CNS Drugs, 20, 655–663. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1686327010.2165/00023210-200620080-00004
   PubMed Web of Science ®Google Scholar
• Wu, C.-L., Doong, M.-L., & Wang, P.S. (2008). Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by oxytocin in ovariectomized rats. European Journal of Pharmacology, 580, 407–415. doi: 10.1016/j.ejphar.2007.11.024
   PubMed Web of Science ®Google Scholar
• Wu, Q., Boyle, M.P., & Palmiter, R.D. (2009). Loss of GABAergic signaling by AgRP neurons to the parabrachial nucleus leads to starvation. Cell, 137, 1225–1234. doi: 10.1016/j.cell.2009.04.022
   PubMed Web of Science ®Google Scholar
• Yamashita, M., Takayanagi, Y., Yoshida, M., Nishimori, K., Kusama, M., & Onaka, T. (2013). Involvement of prolactin-releasing peptide in the activation of oxytocin neurones in response to food intake. Journal of Neuroendocrinology, 25, 455–465. doi: 10.1111/jne.12019
   PubMed Web of Science ®Google Scholar
• Yilmaz, Z., Hardaway, J.A., & Bulik, C.M. (2015). Genetics and epigenetics of eating disorders. Advances in Genomics and Genetics, 5, 131–150. doi: 10.2147/AGG.S55776
   PubMedGoogle Scholar
• Zarjevski, N., Cusin, I., Vettor, R., Rohner-Jeanrenaud, F., & Jeanrenaud, B. (1993). Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology, 133, 1753–1758. doi: 10.1210/endo.133.4.8404618
   PubMed Web of Science ®Google Scholar
• Zerwas, S., & Bulik, C.M. (2011). Genetics and epigenetics of eating disorders. Psychiatric Annals, 41, 532–538. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/2622921110.3928/00485713-20111017-06
   PubMed Web of Science ®Google Scholar
• Zhang, G., & Cai, D. (2011). Circadian intervention of obesity development via resting-stage feeding manipulation or oxytocin treatment. American Journal of Physiology, Endocrinology and Metabolism, 301, E1004–E1012. doi: 10.1152/ajpendo.00196.2011
   Web of Science ®Google Scholar
• Zhou, Y., & Kreek, M.J. (2015). Persistent increases in rat hypothalamic POMC gene expression following chronic withdrawal from chronic “binge” pattern escalating-dose, but not steady-dose, cocaine. Neuroscience, 289, 63–70. doi: 10.1016/j.neuroscience.2014.12.078
   PubMed Web of Science ®Google Scholar
• Zhu, Y., Yamanaka, A., Kunii, K., Tsujino, N., Goto, K., & Sakurai, T. (2002). Orexin-mediated feeding behavior involves both leptin-sensitive and -insensitive pathways. Physiology & Behavior, 77, 251–257. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1241940110.1016/S0031-9384(02)00843-0
   PubMed Web of Science ®Google Scholar
• Zwanzger, P., Domschke, K., & Bradwejn, J. (2012). Neuronal network of panic disorder: The role of the neuropeptide cholecystokinin. Depression and Anxiety, 29, 762–774. doi: 10.1002/da.21919
   PubMed Web of Science ®Google Scholar